NASDAQ:MZOR - Mazor Robotics Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$58.23
+0.30 (1.20%)
Get New Mazor Robotics Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MZOR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MZOR

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Mazor Robotics in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $58.23.

This chart shows the closing price for MZOR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Mazor Robotics. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/15/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/13/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/12/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/12/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/10/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/8/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/7/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/7/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/7/2018Needham & Company LLCReiterated RatingHoldLow
9/21/2018Needham & Company LLCUpgradeUnderperform ➝ HoldHigh
8/2/2018Needham & Company LLCReiterated RatingSellHigh
5/31/2018Cantor FitzgeraldInitiated CoverageNeutral$57.00Low
5/15/2018Wells Fargo & CompanyBoost Price TargetMarket Perform$56.00 ➝ $62.00Medium
5/14/2018Needham & Company LLCReiterated RatingSellLow
3/16/2018Needham & Company LLCDowngradeHold ➝ UnderperformHigh
2/14/2018Needham & Company LLCReiterated RatingHoldHigh
1/9/2018BarclaysReiterated RatingSell$36.00Medium
11/7/2017Needham & Company LLCReiterated RatingHoldN/A
10/30/2017LADENBURG THALM/SH SHSet Price TargetBuy$67.00N/A
10/19/2017BarclaysDowngradeEqual Weight ➝ Underweight$55.00 ➝ $34.00N/A
10/11/2017BarclaysReiterated RatingHold$34.00N/A
8/30/2017Needham & Company LLCReiterated RatingHoldLow
8/30/2017LADENBURG THALM/SH SHSet Price TargetBuy$46.00 ➝ $54.00High
7/6/2017Needham & Company LLCReiterated RatingHoldMedium
6/12/2017LADENBURG THALM/SH SHReiterated RatingBuy$46.00High
5/24/2017Needham & Company LLCReiterated RatingHoldLow
5/15/2017B. RileyReiterated RatingNeutral$31.00High
5/12/2017JMP SecuritiesDowngradeOutperform ➝ Market PerformMedium
5/11/2017Needham & Company LLCReiterated RatingHoldHigh
5/11/2017Wells Fargo & CompanyDowngradeOutperform ➝ Market PerformHigh
5/11/2017First AnalysisDowngradeOverweight ➝ Equal Weight$28.00 ➝ $38.00High
5/10/2017B. RileyReiterated RatingNeutral$31.00High
4/24/2017B. RileyReiterated RatingNeutral$25.00Low
4/24/2017BarclaysDowngradeOverweight ➝ Equal Weight$31.00 ➝ $32.00High
4/19/2017B. RileyReiterated RatingNeutral$25.00High
4/19/2017Standpoint ResearchDowngradeBuy ➝ Reduce$32.98 ➝ $28.00Low
2/22/2017B. RileyReiterated RatingNeutral$25.00N/A
2/17/2017B. RileyReiterated RatingNeutral$25.00N/A
1/5/2017LADENBURG THALM/SH SHSet Price TargetBuy$34.00N/A
(Data available from 12/7/2016 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/11/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/10/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/10/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/9/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/8/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/8/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/7/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/7/2021

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Mazor Robotics logo
Mazor Robotics Ltd., together with its subsidiaries, engages in the development, production, and marketing of medical devices for supporting surgical procedures in the fields of orthopedics and neurosurgery in the United States and internationally. It operates in the field of computer assisted surgery that enable the use of surgical instruments with high precision and minimal invasiveness and that simplifies complex surgical procedures. The company's surgical robotic-guidance systems and complementary products are used to conduct spine and brain procedures in an accurate and secure manner. It also offers Mazor X, a renaissance system and its accessories are used in spine surgeries, including fusion, correction of spinal deformities, biopsy collection, tumor excision, and cement augmentations. The company was formerly known as Mazor Surgical Technologies Ltd. and changed its name to Mazor Robotics Ltd. in 2010. Mazor Robotics Ltd. was founded in 2000 and is based in Caesarea, Israel.
Read More

Today's Range

Now: $58.23
Low: $58.23
High: $58.23

50 Day Range

MA: $58.23
Low: $58.23
High: $58.23

52 Week Range

Now: $58.23
Low: $41.60
High: $76.56

Volume

37 shs

Average Volume

292,420 shs

Market Capitalization

$1.53 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.39

Frequently Asked Questions

What sell-side analysts currently cover shares of Mazor Robotics?

The following sell-side analysts have issued research reports on Mazor Robotics in the last twelve months:
View the latest analyst ratings for MZOR.

What is the current price target for Mazor Robotics?

0 Wall Street analysts have set twelve-month price targets for Mazor Robotics in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Mazor Robotics in the next year.
View the latest price targets for MZOR.

What is the current consensus analyst rating for Mazor Robotics?

Mazor Robotics currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for MZOR.

What other companies compete with Mazor Robotics?

How do I contact Mazor Robotics' investor relations team?

Mazor Robotics' physical mailing address is 5 SHACHAM STREET NORTH INDUSTRIAL PARK, CAESAREA L3, 3088900. The medical instruments supplier's listed phone number is 972-4618-7101 and its investor relations email address is [email protected] The official website for Mazor Robotics is www.mazorrobotics.com.